The Vita Coco Company, Inc. (COCO): what the price assumes

In the published model solve dated 2026-Q2, anchored at $61.71, The Vita Coco Company, Inc. (COCO) is priced for +21.2% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-07-25.

Generated: 2026-08-30 · Source: https://boothcheck.com/report/COCO

Headline

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

The operating-margin figure is value-band context at year 10: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

Solve inputs: computed at a 9.5% cost of capital with 4% terminal growth over a 5-year stage.

How unusual the bet is: within-range (limited comparison data)

Valuation X-Ray

Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium).

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

Families that justify the price: Growth Families that call it expensive: Asset, Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 9.2%); the inversion above states its own rate.

Per-Model Detail (n=18)

Solvency

Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.

Bullet Takeaways

• One product category carries the company: branded coconut water is 81% of revenue, and the filing states plainly that Our flagship brand, Vita Coco , is the market leader in the coconut water category in the U.S.
• Shelf space, not consumer demand, is the concentrated risk: two customers together accounted for roughly 44% of total net sales as of December 31, 2025, and the same retailers also carry the private-label business, whose net sales fell 26.4% due to lost regions with key retailers.
• The company reported second-quarter 2026 results on July 23, 2026 with net sales up 28% and raised its full-year outlook, days after agreeing to buy Copra for 175 million dollars upfront.

Bull Case

Almost every standard way of valuing a business lands well under this price, and the one that reaches it is the one that credits the future. The price sits at more than four times what the asset-value approaches reach and more than four times the earnings-power approaches, with peer multiples about half again below it. Only the forward-growth methods get there. That configuration is not a warning label by itself. It is what a market looks like when it is paying for something the backward-looking frames have no way to measure, and here the thing being measured is a category the company invented and still leads.

Vita Coco does not compete for share of an established shelf; it created the shelf. The filing names the field: competition comes from The Coca-Cola Company, PepsiCo, Inc., and Nestlé S.A. that may have substantially greater financial resources and stronger brand recognition than we have alongside coconut-water specialists such as Goya, and the company still holds the leading position in the category in its home market. Category leadership in a beverage niche is a durable asset in a way that a comparable share of a commodity aisle is not. The brand IS the category for a meaningful slice of shoppers, and the private-label business it runs alongside gives it a second seat at the same retailer's table.

The growth is not a projection; it is in the segment disclosures. International net sales rose 27.3 million dollars, or 37.1%, on 33.7% volume growth in the most recent full year. Product extensions moved even faster: net sales for the Other category increased 12.6 million dollars, or 137.3%, driven by CE volume increase of 178.2% as Vita Coco Treats launched nationally. A brand that can launch an adjacent product nationally and more than double a line item in one year is demonstrating the thing the price is paying for, which is that the franchise travels beyond its original bottle.

The economics behind that growth are already respectable and are not financed by anybody else. Trailing operating margin runs about 16.0% on roughly 660 million dollars of revenue, with no funded borrowings and a little over 200 million dollars of net cash. For context on where that margin can go, FIZZ earns a 19.5% operating margin on 1.18 billion dollars of revenue and MNST earns 29.3% on 8.79 billion. Vita Coco is the smallest of that group by a wide margin, and beverage economics generally improve with scale in procurement, freight and promotional leverage. The path from sixteen to the high teens does not require inventing anything.

Management has also been reliable about its own bar, raising guidance nine times and reaffirming it four times since 2022. That record matters more than usual for a company whose price depends on forward delivery, because it is the only evidence available that the forward numbers mean something. The honest concession is that the price now assumes this continues for years, and a single soft season would remove the assumption faster than it was earned.

Bear Case

Look at what the balance sheet actually holds, because it is the shortest route to the risk here. Book value comes to 5.82 dollars a share against a stock trading in the sixties. Almost the entire market value is brand equity and retail shelf position, neither of which appears anywhere in the accounts and neither of which can be liquidated. The company carries essentially no borrowings, which is genuinely good, but debt-free and resilient are not the same claim. What the balance sheet does carry is inventory sitting inside a very slow physical loop, and that loop is where the fragility lives.

The 10-K describes the loop without euphemism. our product takes many weeks to arrive at our warehouses from our manufacturing partners, which reduces our flexibility to react to short term or unexpected consumer demand changes, or changes in transit times, as it can require planning as much as six months in advance to coordinate all materials for production, and given our supply chain is dependent on ocean freight for shipping coconut water from the source countries to the end use markets the company sits downstream of shipping markets it does not control. Committing inventory two quarters before you know whether the shelf wants it is a working-capital bet placed in the dark. In a soft season the goods still arrive.

Who buys them is concentrated to an uncomfortable degree. Two customers represented approximately 44% of total net sales as of December 31, 2025, and No other customer or distributor represented more than 10% of our total net sales as of December 31, 2025. The stress scenario is not a consumer walking away from coconut water. It is a category manager reallocating facings, and the record already shows what that looks like: private-label net sales fell 26.4% due to lost regions with key retailers. One retailer decision moved a whole product line by a quarter. The same retailers hold the branded business too, and in the distribution network the company notes that we are not always a top priority for our DSD network.

Costs have been moving against the story in the meantime. In the most recent full year, cost of goods sold rose 70.0 million dollars, or 22.1%, driven predominantly by the CE volume increase and the impact of tariffs, in addition to cost increases for finished goods and domestic logistics costs, while gross profit grew 12.0%. Volume was pulling costs up faster than it was pulling profit up, with trade policy named explicitly as one of the reasons. A company that imports a heavy liquid from tropical source countries has direct, unhedgeable exposure to both freight rates and tariff schedules.

All of which matters because of what the current level demands. The market is paying roughly 34 times company-wide operating income, which requires operating profit to compound at something like 30.7% a year for five years. Take every company that has ever run at that clip: only about 27% of them held the pace for five full years. The multiple itself, meanwhile, sits at the very top of its peer distribution, well beyond the upper quartile. The per-share arithmetic is slightly worse than the company arithmetic: the share count has risen about 2.1% a year over the four years to March 2026, so holders capture somewhat less than whatever the business delivers. If growth lands in the teens rather than the thirties, nothing on the balance sheet catches the difference.

Valuation

A single product category carries 81% of revenue, which makes the bet embedded in this price unusually easy to state and unusually hard to hedge.

The market is paying about 34 times company-wide operating income. Run backwards, that embeds operating-profit growth of roughly 30.7% a year over a five-year stage, computed at a 9.46% cost of capital. The pace itself is not beyond what the company has recently delivered; the demand is that it keep delivering it. Two reference points frame how unusual that is. Take the set of companies that have ever run at a comparable clip. Only about 27% of them held the pace a full five years, which is closer to a one-in-four proposition than a base case. Measured against its own cohort, the multiple sits at the very top of the distribution, well beyond the upper quartile, and that is the rarer of the two observations. The arithmetic is also delicate: one percentage point on the cost of capital moves the growth the price requires by more than six percentage points, so the assumption is as much a statement about interest rates as about coconut water.

The methods disagree in a way that is entirely consistent with that. Only the forward-growth approaches reach this price. It sits at more than four times what the asset-value approaches reach and more than four times what the earnings-power approaches reach, with the peer-multiple approaches roughly half again below it. The static frames are not being obtuse. They measure profit already banked and assets already owned, and this company's value is neither: it is a brand position and a distribution footprint that only show up in future income statements. The spread between the growth methods and everything else IS the premium being paid for that durability.

Against the cohort, the operating economics are mid-pack and the size is not. MNST turns 8.79 billion dollars of revenue into a 29.3% operating margin, KDP 16.94 billion into 20.8%, FIZZ 1.18 billion into 19.5%, and BRBR 2.33 billion into 12.5%. Vita Coco turns roughly 660 million into 16.0%. It is by far the smallest of that set, which cuts both ways: less procurement and freight leverage today, but more distance available before scale economics run out. What it does not have is the margin of a Monster or a Keurig Dr Pepper while carrying a multiple above both.

The balance sheet removes the failure scenarios and none of the disappointment scenarios. There are no funded borrowings and a little over 200 million dollars of net cash, so a bad year is an earnings event rather than a solvency one. The offsetting detail is dilution: the share count has drifted up about 2.1% a year over four years, which quietly taxes whatever growth arrives. Put those together and the price is not asking whether the company survives. It is asking whether a beverage brand that has already been the fastest thing in its aisle can stay that way for another five years, in a category any of three global bottlers could decide to contest.

Catalysts

The most recent print landed on July 23, 2026, and it was strong. Second-quarter 2026 net sales grew 28%, with revenue of 216.15 million dollars against a second-quarter 2026 consensus of 210.64 million, and management raised the full-year outlook. That combination, a beat plus a raise, is the specific evidence the durability case requires, and it arrived after the trailing twelve-month figures underlying most valuation work were struck.

The larger development was structural rather than seasonal. Vita Coco agreed to acquire Copra for 175 million dollars in upfront consideration, moving into the super-premium Thai coconut water segment. Two things follow. The deal takes the company up-market inside its own category rather than sideways into an adjacent one, which is a different strategic choice from launching a Treats line. And the upfront consideration is close to the entire net cash position, so a balance sheet that had been a source of optionality becomes, for a while, a balance sheet that has spent it. How the purchase is financed and what Copra contributes to margin are the two things worth reading in the next filing.

The sell side moved immediately and in one direction. Piper Sandler raised its target to $89 from $74 with an Overweight rating and Goldman Sachs to $90 from $81 with a Buy. Those levels sit well above where the standard valuation approaches, other than the forward-growth ones, currently land. The gap is not a contradiction so much as a statement of what the street is crediting: the raised full-year guidance and the acquisition, neither of which is present in the trailing results the static methods read.

Peer Cohorts (Per Segment, With Filing Citations)

Core business (reported)

• FIZZ (National Beverage Corp.)
• FY2025 10-K: …and our competitive position may vary by market area. Our products compete with many varieties of liquid refreshment, including water products, soft drinks, juices, fruit drinks, energy drinks and sports drinks, as well as powdered drinks, coffees, teas, dairy- based drinks, functional beverages and various other…
• FY2025 10-K: …case volume. The average cost of sales per case remained relatively unchanged and gross margin increased to 37.0% compared to 36.0% for Fiscal 2024. Shipping and handling costs are included in selling, general and administrative expenses, the classification of which is consistent with many beverage companies.…
• CELH (CELSIUS HOLDINGS, INC.)
• FY2025 10-K: …our future revenues and profitability. 18 The increasing number of competitive products and limited availability of shelf and cooler space in retail outlets may limit our ability to maintain or expand our market presence. Competitors may engage in aggressive marketing, offer price discounts or pursue false or…
• FY2025 10-K: …Our products compete with all liquid refreshments and with products of certain competitors that are much larger, some of which have significantly greater financial resources, such as Monster Beverage Corporation, Red Bull GmbH, The Coca-Cola Company, Pepsi, Keurig Dr Pepper Inc., Nestlé S.A., BlueTriton Brands,…
• PRMB (Primo Brands Corp)
• FY2025 10-K: …operating efficiencies, cost savings, revenue enhancements, and other benefits from the Transaction. We face significant competition in the segment in which we operate. We participate in the highly competitive beverage and bottled water category of the non-alcoholic beverage industry. We face significant competition…
• FY2025 10-K: …products, such as pitchers and jugs, standard and advanced feature water coolers, and refrigerator-dispensed filtered water. Consumers may also choose to drink from municipal water sources instead of purchasing bottled water or using a filtration unit. If our competitors reduce their selling prices, develop new and…
• MNST (Monster Beverage Corp)
• FY2025 10-K: …Bull GmbH, KDP, Molson Coors, Constellation Brands, AB InBev, The Boston Beer Company and The Mark Anthony Group. We also compete with companies that are smaller or primarily national or local in operations, such as CELSIUS, PRIME, C4, Alani Nu, GHOST, ZOA, GORGIE, and others as well as local craft breweries in our…
• FY2025 10-K: …Strategic Brands segment primarily generates net operating revenues by selling "concentrates" and/or "beverage bases" to authorized bottling and canning operations. Such bottlers generally combine the concentrates and/or beverage bases with sweeteners, water and other ingredients to produce ready-to-drink packaged…
• KDP (Keurig Dr Pepper Inc.)
• FY2025 10-K: Financial Statements for additional information on the JDE Peet's Acquisition and related transactions. On August 25, 2025, we announced our intention to separate our beverage and coffee portfolios into two independent, publicly traded companies, which will allow for more tailored growth strategies, operating models,…
• FY2025 10-K: …their route-to-market, reducing prices, or increasing promotional activities. We also compete with various smaller or regional companies and private label manufacturers, which may be more innovative, better able to bring new products to market, and better able to quickly serve niche markets. Additionally, we compete…
• BRBR (BellRing Brands, Inc.)
• FY2025 10-K: …Competition The convenient nutrition category in which we operate is highly competitive and highly sensitive to both pricing and promotion. We compete with other brands, including private label and store brand products, and with many nutritional food and beverage players. We have numerous competitors of varying…
• FY2025 10-K: …due to manufacturer inability, supply chain failures or otherwise, or our failure or inability to provide sufficient investment to support and market those products as needed to maintain or grow their competitive position or to achieve more widespread market acceptance. We operate in a category with strong…
• SAM (THE BOSTON BEER COMPANY, INC.)
• FY2025 10-K: …significantly greater resources than the Company. This competitive environment may affect the Company's overall performance within the Beyond beer and Traditional beer categories. As the market continues to consolidate, the Company believes that companies that are well-positioned in terms of brand equity, marketing…
• FY2025 10-K: Company anticipates competition will remain strong as existing beverage companies continue adding more SKUs and styles. The potential for growth in the sales of flavored malt beverages, hard seltzers, domestic beers, imported beers and spirits RTDs is expected to increase the competition in the market for Beyond beer…

Methodology Note

• Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
• Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
• Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
• Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.